Sareum (LON:SAR) Stock Crosses Above 50-Day Moving Average – Here’s Why

Sareum Holdings plc (LON:SAR) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 15.56 and traded as high as GBX 20. Sareum shares last traded at GBX 19.53, with a volume of 73,599 shares trading hands.

Sareum Price Performance

The company’s fifty day simple moving average is GBX 15.68 and its 200 day simple moving average is GBX 18.12. The firm has a market capitalization of £26.92 million, a PE ratio of -5.42 and a beta of -1.08.

Sareum (LON:SAR) last posted its earnings results on Thursday, October 23rd. The company reported GBX (2.40) earnings per share for the quarter. Equities research analysts forecast that Sareum Holdings plc will post -3.8 EPS for the current year.

Sareum Company Profile

Sareum is a specialist drug development company delivering targeted small molecule therapeutics to improve the treatment of cancer and autoimmune diseases. The Company aims to generate value through licensing its candidates to international pharmaceutical and biotechnology companies at the preclinical or early clinical trials stage.
Sareum is advancing internal programmes focused on distinct dual tyrosine kinase 2 (TYK2) / Janus kinase 1 (JAK1) inhibitors through preclinical development as therapies for autoimmune diseases, including the ‘cytokine storm’ immune system overreaction to Covid-19 and other viral infections, (SDC-1801) and cancer immunotherapy (SDC-1802).
Sareum also has an economic interest in SRA737, a clinical-stage oral, selective Checkpoint kinase 1 (Chk1) inhibitor that targets cancer cell replication and DNA damage repair mechanisms.